Company / Operating Income per Share
Mirum Pharmaceuticals, Inc. Operating Income per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.46
FY2025
5-year range
-$5.67 / -$0.46
FY2021-FY2025
Trend
+75.6%
vs FY2024
Sector context
#74 of 201
Health Care
What the data says
At $-0.46, Mirum Pharmaceuticals, Inc.'s operating income per share ranks #74 of 201 in the Health Care sector. Operating Income per Share has increased for 3 consecutive years, from $-5.67 in FY2022 to $-0.46 in FY2025.
Based on SEC 10-K filings.
-0.46 in FY2025.
Improved from $-2.95 to $-0.46 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#74 of 201 in Health CareTop 37% of 201This company -$0.46 Sector average -$3.23
▼
+85.8% above sector average
Key checks
Key Insights
- Mirum Pharmaceuticals, Inc.'s operating income per share has grown for 3 consecutive years.
- In FY2025, operating income per share increased 75.6% year-over-year.
- Ranks #74 out of 201 companies in the Health Care sector.
- Lowest operating income per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -26.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.46 | +75.6% |
| FY2024 | -$1.88 | +36.5% |
| FY2023 | -$2.95 | +47.9% |
| FY2022 | -$5.67 | -61.9% |
| FY2021 | -$3.50 | +15.2% |
| FY2020 | -$4.13 | +13.3% |
| FY2019 | -$4.77 | +75.4% |
| FY2018 | -$19.35 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026